1 asset in PPoma
Therapeutic assets addressing PPoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Capecitabine PPoma | ECOG-ACRIN Cancer Research Group | P2 | B (57) |
Therapeutic assets addressing PPoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Capecitabine PPoma | ECOG-ACRIN Cancer Research Group | P2 | B (57) |